Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nitric oxide delivery to cancer: Why and how?

(2009) Pierre Sonveaux et al.   EUROPEAN JOURNAL OF CANCER

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

(2009) Tetsuya Mitsudomi et al.   LANCET ONCOLOGY

Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance

(2008) E L Leung et al.   BRITISH JOURNAL OF CANCER

Biogenesis of Short Intronic Repeat 27-Nucleotide Small RNA from Endothelial Nitric-oxide Synthase Gene

(2008) Ming-Xiang Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of 27nt Small RNA on Endothelial Nitric-Oxide Synthase Expression

(2008) Ming-Xiang Zhang et al.   MOLECULAR BIOLOGY OF THE CELL

Tumour maintenance is mediated by eNOS

(2008) Kian-Huat Lim et al.   NATURE